These kits are designed to concurrently isolate fragmented cfDNA and cfRNA from serum and plasma without needing large sample volumes. Through the use of sophisticated silica-column technology, they guarantee genomic integrity and remove enzymatic inhibitors, making them crucial for multi-omics integration, non-invasive therapeutic candidate evaluation, and early disease monitoring.
What you will discover:
MBP Inc. offers tools that have been tested for reproducibility, enabling scalable and uniform biomarker isolation. These kits provide the high-quality data needed for sophisticated clinical and translational studies.
Reach out to the professional team at MBP Inc. now to obtain a quote.